Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 4/2011

Open Access 01-10-2011 | Gynecologic Oncology

Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France

Authors: Edouard Vaucel, Marianne Coste-Burel, Christian Laboisse, André Dahlab, Patrice Lopes

Published in: Archives of Gynecology and Obstetrics | Issue 4/2011

Login to get access

Abstract

Objective

The objective was to assess the human papillomavirus (HPV) overall and type-specific prevalence in smears collected during routine clinical practice.

Design

HPV genotyping and smears were performed independently between 2000 and 2006 for routine clinical follow-up (primary screening and follow-up) in the University Hospital of Nantes, France.

Population

All women with a cytological sample collected no more than 12 months before HPV genotyping were included.

Methods

PCR was performed with MY09/MY11 primers and genotyping by sequencing PCR product.

Main outcome measures

Overall and genotype-specific HPV prevalence were assessed according to cytological diagnosis.

Results

A total of 1,255 women were included (mean age 37.5 years). The proportion of high-risk (HR) HPV positive samples increased according to cytological diagnosis severity from 8% in normal specimens to 21% in atypical squamous cells of undetermined significance, 49% in low-grade squamous intraepithelial lesion and 75% in high-grade squamous intraepithelial lesion (HSIL) (p < 0.001). Among 980 women with normal cytology, the overall HPV prevalence varied according to age from 44% below 20 years to about 10% above 35 years (p < 0.001). The most prevalent HPV genotype in all cytological diagnoses was HPV 16. HPV 53 appeared as the second most common genotype in normal cytological samples (10.9% of HPV positive samples) but its prevalence decreased in HSIL to less than 4%.

Conclusion

The proportion of HR HPV positive women increased according to cytological diagnosis severity. HPV 16 appeared as the most commonly encountered genotype even when the diagnosis was normal. Its prevalence increased with diagnosis severity hereby confirming that HPV 16 is more aggressive than other genotypes.
Literature
1.
Dalstein V, Briolat J, Birembaut P, Clavel C (2006) The epidemiology of genital human papillomavirus infections. Rev Prat 56:1877–1881PubMed
2.
3.
Wiley D, Masongsong E (2006) Human papillomavirus: the burden of infection. Obstet Gynecol Surv 61:S3–S14PubMedCrossRef
4.
Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef
5.
Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796–802PubMedCrossRef
6.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19PubMedCrossRef
7.
Holowaty P, Miller AB, Rohan T, To T (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91:252–258PubMedCrossRef
8.
Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E (2007) Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives. Cancer Epidemiol Biomarkers Prev 16:709–715PubMedCrossRef
9.
Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE et al (2008) Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 197:1436–1447PubMedCrossRef
10.
Moscicki AB, Schiffman M, Kjaer S, Villa LL (2006) Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 24(Suppl 3):S42–S51CrossRef
11.
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
12.
Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P (2010) Cancer incidence and mortality in France over the period 1980–2005. Rev Épidemiol Santé Publique (in press)
13.
14.
Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR et al (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271–278PubMedCrossRef
15.
Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F et al (2008) Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis 47:610–615PubMedCrossRef
16.
Pretet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J et al (2008) Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol 110:179–184PubMedCrossRef
17.
Pretet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B et al (2008) Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer 122:424–427PubMedCrossRef
18.
Pretet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B et al (2008) Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 122:428–432PubMedCrossRef
19.
Laurendeau I, Bahuau M, Vodovar N, Larramendy C, Olivi M, Bieche I et al (1999) TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem 45:982–986PubMed
20.
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M et al (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114–2119PubMedCrossRef
21.
Tumours of the uterine cervix. In: F Tavassoli, P Devilee (eds) Tumours of the breast and female genital organs. WHO classification of tumours. IARC Press, Lyon, 2003
22.
Bergeron C, Cartier I, Guldner L, Lassalle M, Savignoni A, Asselain B (2005) Lésions précancéreuses et cancers du col de l’utérus diagnostiqués par le frottis cervical. Ile-de-France, enquête Crisap, 2002. Bull Epidemiol Hebd 2:5–6
23.
Bergeron C, Cohet C, Bouée S, Lorans C, Rémy V (2007) Management of abnormal smears intraepithelial neoplasia and associated treatment costs in France. Bull Epidemiol Hebd 1:4–6
24.
Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W (2009) Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol 113:595–600PubMed
25.
Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M et al (2001) Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84:1616–1623PubMedCrossRef
26.
Boulanger JC, Sevestre H, Bauville E, Ghighi C, Harlicot JP, Gondry J (2004) Epidemiology of HPV infection. Gynecol Obstet Fertil 32:218–223PubMedCrossRef
27.
de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459PubMedCrossRef
28.
Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N et al (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902–907PubMedCrossRef
29.
Gravitt PE, Coutlee F, Iftner T, Sellors JW, Quint WG, Wheeler CM (2008) New technologies in cervical cancer screening. Vaccine 26(Suppl 10):K42–K52PubMedCrossRef
30.
Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A et al (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38:357–361PubMed
31.
Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS et al (1997) PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304–1310PubMed
32.
Munoz N, Hernandez-Suarez G, Mendez F, Molano M, Posso H, Moreno V et al (2009) Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer 100:1184–1190PubMedCrossRef
33.
Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14:1157–1164PubMedCrossRef
Metadata
Title
Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France
Authors
Edouard Vaucel
Marianne Coste-Burel
Christian Laboisse
André Dahlab
Patrice Lopes
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 4/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1747-z

Other articles of this Issue 4/2011

Archives of Gynecology and Obstetrics 4/2011 Go to the issue

Materno-fetal Medicine

Nifedipine for the treatment of preterm labor in twin and singleton pregnancies

Materno-fetal Medicine

Role of Helicobacter pylori in the pathogenesis of hyperemesis gravidarum

Gynecologic Oncology

Cervical cytology of atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H): histological results and recurrence after a loop electrosurgical excision procedure

Materno-Fetal Medicine

Up-regulated monoamine oxidase in the mouse uterus during the peri-implantation period

General Gynecology

Transumbilical single-incision laparoscopic hysterectomy with conventional laparoscopic instruments in patients with symptomatic leiomyoma and/or adenomyosis

Gynecologic oncology

Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings